Figure 2.
Figure 2. Frequency of prognostically relevant molecular and cytogenetic subgroups of AML arising in younger adults.
 Frequencies of the various entities specified in Table 2 are based on a synthesis of published data 9,16,19–25 and analysis of adults with AML entered into the MRC AML10 and 12 trials.6

Frequency of prognostically relevant molecular and cytogenetic subgroups of AML arising in younger adults.
 Frequencies of the various entities specified in Table 2 are based on a synthesis of published data 9,16,19,–25 and analysis of adults with AML entered into the MRC AML10 and 12 trials.6 

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal